Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2659 |
|
| Actual shortage: | 251 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2399 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
27 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2023-12-07 | 2024-03-21 | 212730 |
| TEVA-CLOXACILLIN | 125MG | GRANULES FOR SOLUTION | Resolved | 2017-08-21 | 2017-09-19 | 19937 |
| TEVA-CLOXACILLIN | 125MG | GRANULES FOR SOLUTION | Resolved | 2021-01-07 | 2021-02-25 | 131063 |
| TEVA-CLOXACILLIN | 125MG | GRANULES FOR SOLUTION | Resolved | 2023-06-08 | 2023-07-05 | 194054 |
| TEVA-CLOXACILLIN | 125MG | GRANULES FOR SOLUTION | Resolved | 2023-06-19 | 2023-10-03 | 195518 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2019-10-03 | 2020-04-02 | 95408 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2019-10-03 | 2020-03-26 | 95411 |
| NOVAMOXIN | 50MG | GRANULES FOR SUSPENSION | Resolved | 2020-02-07 | 2020-06-11 | 105596 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2020-04-10 | 2020-04-23 | 111841 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2020-05-14 | 2020-06-04 | 115196 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2022-05-19 | 2022-07-01 | 160983 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2022-08-18 | 2022-09-08 | 167159 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2022-09-22 | 2024-02-14 | 169966 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2022-10-20 | 2024-02-14 | 172263 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2023-02-02 | 2023-07-05 | 183361 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2023-06-16 | 2023-11-03 | 195109 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2023-06-16 | 2023-10-11 | 195112 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2023-06-16 | 2023-10-11 | 195207 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2023-06-20 | 2023-11-03 | 195754 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Actual shortage | 2023-10-19 | 2024-03-18 | 207503 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |